pad

Gastrointestinal  (gastric, esophageal, small-bowel, hepato,pancre)

pad
padEthnicity in Patterns/Presentation Gastric Adenocarcinoma
pad
Abstract # 4016 ASCO, 2004
pad
pad
padIncidence of Adenocarcinoma in Barrett's Esophagus
pad
Abstract # 4001 ASCO, 2004
pad
pad
pad
padPrognosis of Pts w/ Metastatic Hepatocellular Ca
pad
Abstract # 3127 ASCO, 2004
pad
pad
padAnal Cancer Incidence & HIV Epidemiology
pad
Abstract #4080 ASCO, 2004
pad
Incidence of Anal Cancer in Moslem Societies
pad
pad
padPrimary Peritoneal Mesothelioma: Treatment Issues
pad
Abstract # 4132 ASCO, 2004
pad
pad
padStimulation of NK cells, Pancreatic Ca w/Virulizin
pad
Abstract # 4257 ASCO, 2004
pad
Analysis of Treatment Outcomes in Pancreatic Ca
pad
pad
padQoL Outcomes Colorectal Ca: Integrative Treatment Setting
pad
Abstract # 3694 ASCO, 2004
pad
Gingko Biloba as Neuroprotection Against Oxaliplatin
Responders Can Take Chemo Break: Colorectal Ca (QoL)
IL-2 w 13-cis Retinoic Acid Prolongs DFS/OS: Mets Colon Ca
Racial Diff in Survival: Tumor Diff/Stage Colon Ca
Severe Hepatic Sinusoidal Obstruction W/ Oxaliplatin
Bowel Perforation & Fistula Formation W/Bevacizumab
Genomic Profiling Predicts Toxicity w/Platinum -based Chemo
pad
padDiabetes Mellitus Not Assoc with Increased Overall Mortality
pad
Abstract #3639 ASCO, 2004
pad
pad

Remember we are NOT Doctors and have NO medical training.

This site is like an Encylopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.